Patient resource

Premenstrual dysphoric disorder (PMDD): an NC guide

By Josephine W. Hazeley, MSN, PMHNP-BC
Board-certified psychiatric mental health nurse practitioner with a perinatal & postpartum focus — nearly two decades in psychiatric nursing, including research nursing on the trial behind the first FDA-approved postpartum-depression therapy. About your clinician

Clinically reviewed by Josephine W. Hazeley, PMHNP-BC on · Last updated

Premenstrual dysphoric disorder (PMDD) is a severe, cyclical mood disorder in which depression, irritability, anxiety, or a sense of being out of control climb in the week or two before your period and lift within a few days of it starting. It is a recognized diagnosis, not a character flaw or ordinary “bad PMS,” and it responds to treatment — most often an SSRI, which can be taken every day or only during the premenstrual phase (ACOG). The distinguishing feature is the timing: symptoms track the menstrual cycle and remit after menses.

This guide is education, not a diagnosis for any one person. It covers what PMDD is, how it differs from PMS, how it is actually diagnosed, and the treatment options — including how you can be evaluated by telehealth anywhere in North Carolina.

What is PMDD?

PMDD is the severe end of the premenstrual spectrum. Where most people who menstruate notice some premenstrual discomfort, a smaller group has mood and physical symptoms intense enough to disrupt work, relationships, and daily function — that is PMDD (StatPearls). The Office on Women’s Health describes it as a health problem similar to PMS but more serious, causing severe irritability, depression, or anxiety (womenshealth.gov).

The symptoms cluster in two groups. The mood symptoms are the core: marked irritability or anger, depressed mood or hopelessness, anxiety or tension, and mood swings or sudden tearfulness. Alongside them come symptoms like difficulty concentrating, low energy, changes in sleep and appetite, a feeling of being overwhelmed, and physical complaints such as breast tenderness or bloating (StatPearls). The symptom list alone does not make it PMDD, since many conditions share it. The timing does: symptoms appear in the luteal phase (after ovulation, before your period) and ease off once bleeding begins.

How common is PMDD?

More common than most people realize, and widely under-recognized. Roughly 5% to 8% of women have moderate-to-severe premenstrual symptoms that cause real distress and functional impairment (StatPearls); the Office on Women’s Health puts PMDD at up to 5% of women of childbearing age (womenshealth.gov). Many people live with it for years, having been told it is just PMS, before it is named.

Isn’t this just really bad PMS?

No — the difference is severity and impairment, and it matters because the treatments differ. PMS and PMDD share the same premenstrual timing, but PMS is uncomfortable while PMDD interferes with your life. ACOG frames it directly: if premenstrual symptoms are severe and cause problems with work or personal relationships, that points to PMDD, a severe form of PMS (ACOG). The line worth drawing is functional: cramps and moodiness you can work around are one thing; a monthly stretch where you cannot function, dread the people you love, or think you might be better off gone is another. The second is PMDD, and it is treatable. For a fuller comparison, see PMDD versus PMS.

Why does PMDD happen?

Current understanding is that PMDD is driven by an abnormal sensitivity to the normal hormonal shifts of the menstrual cycle, rather than by abnormal hormone levels (StatPearls). Hormone levels in PMDD are typically normal; the brain’s response to the ordinary rise and fall of progesterone and its metabolites is what differs. This is why “your labs are normal” is not a reason to dismiss PMDD, and why treatments work either by steadying the brain’s response (SSRIs) or by flattening the hormonal cycle itself (certain contraceptives).

How is PMDD diagnosed?

By tracking your symptoms prospectively across at least two menstrual cycles — not by a single visit or a one-time questionnaire. This is the part that surprises people, and it is the most important part to get right.

The formal diagnostic criteria (DSM-5-TR) require at least five symptoms, including at least one core mood symptom, tied to the luteal phase and remitting after menses, causing significant impairment — and, critically, they require confirmation “by prospective daily ratings during at least 2 consecutive symptomatic menstrual cycles” (StatPearls). A prescriber may make a provisional diagnosis to get started, but the confirmation comes from daily records, not memory. The standard tool is the Daily Record of Severity of Problems (DRSP), a validated daily rating scale (C-PASS validation). Prospective tracking also separates PMDD from a mood or anxiety disorder that simply gets worse premenstrually — a different pattern called premenstrual exacerbation. Both are covered in how PMDD is diagnosed and PMDD versus premenstrual exacerbation.

How is PMDD treated?

The first-line medication is an SSRI, and PMDD is unusual in that the medication can be taken two ways. ACOG’s clinical guidance names selective serotonin reuptake inhibitors as first-line pharmacologic treatment for the mood symptoms of premenstrual disorders, and three of them (sertraline, paroxetine, and fluoxetine) carry an FDA indication for PMDD (ACOG CPG No. 7). Unlike depression, where an SSRI is taken daily for months, PMDD often responds to luteal-phase dosing, meaning the medication is taken only during the two weeks before your period, as well as to continuous daily dosing. Sertraline’s FDA label, for example, lists both a continuous and a luteal-phase-only regimen (DailyMed: sertraline). Which approach fits you is a decision you make with a prescriber; this guide does not substitute for that conversation.

SSRIs are not the only option. Certain combined oral contraceptives — specifically a drospirenone-containing pill — are FDA-approved for PMDD and work by steadying the hormonal cycle (Cochrane review). Cognitive behavioral therapy is recommended, and for severe or treatment-resistant cases there are further options such as GnRH agonists with add-back therapy (ACOG CPG No. 7). PMDD treatment options walks through each of these in turn.

When is PMDD an emergency?

When symptoms include thoughts of suicide — which are more common in PMDD than many people are told. PMDD is associated with a substantially elevated risk of suicidal ideation and suicide attempts (Osborn et al., meta-analysis). If premenstrual despair has ever brought you to thoughts of death or self-harm, that is not something to wait out until your period starts.

If you or someone you know is in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911. This applies at any point in the cycle. When premenstrual symptoms become an emergency covers this in more detail, including why the timing can make the risk easy to dismiss.

How do you get evaluated for PMDD in North Carolina?

Through a psychiatric evaluation you can complete by telehealth from anywhere in the state. Mindful Counseling & Wellness provides telehealth psychiatric evaluation and medication management across North Carolina, led by a board-certified psychiatric mental health nurse practitioner (PMHNP-BC) with a focus on reproductive and perinatal mental health. Because PMDD diagnosis depends on prospective tracking, a common first step is to start daily symptom ratings while your intake is scheduled, so the picture is already forming by your first visit — see getting PMDD care by telehealth in NC.

To begin, request an appointment through Get Started or call (919) 739-3808. New patients are typically seen within 1–3 business days, by telehealth anywhere in North Carolina.

If you or someone you know is in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911.

Sources